Table 1. Summary of analyzed articles.
Article | Participant characteristics: sample size (N), disease severity (mean/range; EDSS/PDSS), age (mean years), MS type | Intervention | Assessments |
---|---|---|---|
Martini et al., 2018 [19] | N 40; EDSS:6; Age 56 | Multicomponent walking aid program | TUG, 2MWT, T25W, FSST, MSWS-12, MSIS-29, ABC |
MS type: NR | |||
Russo et al., 2017 [20] | N 45; EDSS:3–5.5; Age 42 | Robot gait training with virtual reality (Lokomat) | TUG, EDSS, TBS, HRSD |
MS type: RR 45 | |||
Sandroff et al., 2017 [21] | N 83; PDDS:4; Age 49.8 | Multimodal exercise training | GSTP, VO2, MS-IM, T25W, 6MWT, MSWS-12 |
MS type: NR | |||
Calabro et al., 2017 [22] | N 40; EDSS: 4.1–5.5; Age 41 | Robot assisted therapy with virtual reality | MAS, MS-LD, TUG, BBS, HRSD, COPE |
MS type: NR | |||
Conroy et al., 2017 [23] | N 24; PDDS:4.4; Age 50.4 | Self-directed exercise at home | T25W, BBS, 6MWT, MSWS-12 |
MS type: RR8, SP15, PP1 | |||
Pau et al., | N 22; EDSS: 3.6; Age 47.4 | Adapted physical activities | ROM, GSTP |
2017 [24] | MS type: NR | ||
Pompa et al., 2016 [25] | N 43; EDSS: 6–7.5; Age 47 | Robot assisted gait training + conventional rehabilitation | VAS, FSS, EDSS, 2MWT, FAC |
MS type: SP40, PP3 | |||
Davies et al., | N 32; EDSS: 5.4; Age 53.3 | High frequency physical therapy | GSTP, 6MWT |
2016 [26] | MS type: RR22, SP10 | ||
Kalron et al., 2016 [27] | N 45; EDSS:4.6; Age 44.3 | Pilates/physical therapy for improving gait | FIS, TUG, 2MWT, FSST, BBS, 6MWT, MSWT-12 |
MS type: RR45 | |||
Straudi et al., 2016 [28] | N 52; EDSS:6.43; Age 52.3 | Robot assisted gait training | FSS, TUG, BBS, 6MWT, 10m, QoLSF-36, PHQ-9 |
MS type: SP36, PP16 | |||
Straudi et al., 2014 [29] | N 24; EDSS:4.89; Age 52.6 | Task oriented circuit training | FSS, TUG, 6MWT, DGI, MSWS-12, MSIS-29 |
MS type RR6, SP8, PP10 | |||
Tyler et al., 2014 [30] | N 20; EDSS:5.25; Age:55.4 | Non-invasive neuromodulation/physical therapy | DGI |
MS type: RR13, SP6, PP1 | |||
Aydin et al., 2014 [31] | N 40; EDSS:3.6; Age 33 | Home based calisthenic exercises | FSS, BBS, 10m, HADS, MusiQoL |
MS type: RR40 | |||
Ruiz et al., 2013 [32] | N 7; EDSS: 5; Age 47 | Robot assisted, body weight support training | GSTP, T25W, FRT, 6MWT |
MS type: RR5, PP2 | |||
Schwartz et al., 2012 [33] | N 32; EDSS: 6; Age 48.6 | Robot assisted gait training | TUG, EDSS, BBS, 6MWT, 10m, Rand-36 |
MS type: NR | |||
Vaney et al., 2012 [34] | N 49; EDSS:5.8; Age 56.2 | Robot assisted step training (Lokomat) | MAS, VAS, BBS, 3MWT, 10m, Ac, WE |
MS type: NR | |||
Dodd et al., | N 71; EDSS:0–6.5; Age49 | Progressive resistance training | MSSS-88, MS-MD, FIS,2MWT, WHOQoL-Bref |
2011 [35] | MS type: RR71 | ||
Conklyn et al., 2010 [36] | N 10; EDSS NR Age: 48.5 | Home based walking program (rhythmic auditory) | MAS, VAS, MRC, Kinematics, PDDS, T25W, AI |
MS type: RR7, SP2, PP1 | |||
Cakit et al., 2010 [37] | N 45; EDSS:0–6; Age 38.1 | Cycling progressive resistance training programs | FSS, TUG, FRT, 10m, DGI, FES, QoLSF-36, BDI |
MS type: NR | |||
Robinson et al., 2015 [38] | N 56; EDSS:0–6; Age 52.9 | Exergaming | GSTP, MSW-12, WHODAS2.0 |
MS type: NR | |||
Garret et al., 2013 [39] | N 121; GNDRS:0,1–2; Age50.05 | Circuit exercises, aerobic exercise, yoga | FIS, GNDS,6MWT, MSIS-29 |
MS type: RR65, SP20, PP13, Bening 5 Unknown 18 | |||
Gandolfi et al., 2014 [40] | N 22; EDSS:4.1; Age 50.4 | Robot assisted gait training | GSTP, FSS, BBS, SOT, SA, MSQoL-54, ABC |
MS type: NR | |||
Peruzzi et al., 2017 [41] | N 25; EDSS:3.8; Age 42.8 | Virtual reality and treadmill | ROM, Kinematics, TUG, EDSS, FSST, BBS,6MWT |
MS type: NR | |||
Shahraki et al., 2017 [42] | N 18; EDSS:3–6.0; Age 39.2 | Gait training/ rhythmic auditory stimulation | GSTP |
MS type: NR | |||
Braendvik et al., 2016 [43] | N 29; EDSS:3.2; Age 47.9 | Treadmill training | GSTP, Ac |
MS type RR19 SP2 PP5 | |||
Straudi et al., 2019 [44] | N 72; EDSS:6.5; Age 55.5 | Robot assisted gait training | FSS, TUG, T25W, MSWS-12, QoLSF-36, MSIS-29, PHQ-9 |
MS type SP38 PP34 | |||
Heine et al., 2019 [45] | N 10; EDSS:3; Age 48.8 | Sequential exercise intervention | GSTP, CPET, MFIS, FMSC, MSWS-12 |
MS type RR2 SP3 PP5 | |||
Callessen et al., 2019 [46] | N 142; EDSS:2–6.5; Age 52 | Resistance, Balance, Motor Control training | T25FW, SSST, mBest test, 6MWT, FIS, MS-IM, MSWS-12, CTSIB, ABC |
MS type RR99 SP25 PP18 | |||
Hochsprung et al., 2020 [47] | N 61; EDSS:2.5–6.5; Age NR | Cycling training with visual feedback | GSTP |
MS type RR27 SP20 PP14 | |||
Manca et al., 2020 [48] | N 28; EDSS:2.0–5.5; Age 46 | High-intensity resistance training | GSTP, ROM, MS-IM |
MS type RR28 | |||
Mahler et al., 2018 [49] | N 34; EDSS:3.0; Age 50 | Robot assisted gait training/ | 6MWT, 10MWT, Calorimetry, WLT |
MS type RR 34 | Overground walking training | ||
Mansour 2013 [50] | N 24; EDSS 2.9; Age 40,42 | Partial body weight supported treadmill training | TUG, GSTP, Kinematics |
MS type RR 24 | |||
Manca et al., 2017 [51] | N 30; EDSS:3.4; Age 45.1 | Strength training | 2MWT, 6MWT, 10MWT, TUG, MS-IM |
MS type RR30 | |||
Felippe et al., 2019 [52] | N 28; EDSS3.0; Age 50 | Treadmill training | TUG, MMSE, FAB |
MS type RR 28 | |||
McGibbon et al., 2018 [53] | N 29; EDSS:5.2; Age NR | Robot assisted gait training | 6MWT, TUG, TST, Ac |
MS type NR | |||
Munari et al.,2020 [54] | N 17; EDSS:5.2; Age 54.35 | Robot assisted gait training, Virtual reality | PASAT, 2MWT, MSQoL-54, 10MWT, GSTP |
MS type RR 4 SP 14 | |||
Flachenecker et al, 2020 [55] | N 84; EDSS:4.1; Age 47 | Internet-based exercise program | WEI-MuS, MSIS-29, 2MWT, 10MWT, TBS |
MS type RR 39 SP45 | |||
Elwishly et al.,2020 [56] | N 29; EDSS: 4–6; Age 33.1 | Dual task training | 2MWT, 10mWT, MMSE, EDSS |
MS type RR 29 | |||
Esnouf et al., 2010 [57] | N 53; EDSS:5.6; Age 55 | FES | COMP, FD |
MS type RR 53 | |||
Feys et al., 2019 [58] | N 35; EDSS:NR; Age 40.5 | Start to run program | VO2, STST, 6MWT, MSFCS, FSMCF, MSIS-29, DTI |
MS type NR | |||
Gutierrez et al., 2020 [59] | N 31; EDSS: 3.7; Age 43.5 | Strength and dual task combined training program | MS-SS, STS, SA, GSTP |
MS type NR | |||
Tollar et al., 2020 [60] | N 68; EDSS:5–6; Age | Exercise therapy | MSIS-29, QoLEQ-5D, TBS, BBS, 6MWT, SA |
MS type | |||
Vedkamp et al., 2019 [61] | N 40; EDSS: 3.5; Age 40 | Dual task training | T25WT, TUG, DGI, 2MWT, MSWS-12, FES, MSIS-29 |
MS type | |||
Kahraman et al, 2020[62] | N 35; EDSS: 1.5; Age 35.2 | Motor imagery | DGI, T25WT, 2MWT, MSWS-12, TUG, ABC, MFIS, HADS, SA, SDMT, SRT |
MS type NR | |||
Renfrew et al., 2018 [63] | N 78; EDSS: 5.0; Age 39 | Electrical stimulation | 5MWT, VO2, 25FWT |
MS type RR35 SP18 PP13 NR 12 | |||
Duff et al., 2018 [64] | N 30; EDSS:NR, PDDS: 2.2; Age 45.5 | Pilates | 6MWT, TUG, MSQoL-54, FBS, SRT, Ac, MVC |
MS type RR 25, SP 2, PP 3 |
Abbreviations: N Number of participants; EDSS Expanded disability status scale; PDDS Patient determined disease steps; NR Not reported; TUG Timed up and go test; 2MWT 2 minute walking test; T25W Timed 25 foot walk; FSST Four square step test; MSWS-12 Multiple sclerosis walking scale-12; MSIS-29 Multiple sclerosis impact Scale_29; ABC Activities-specific balance confidence scale; TBS Tinetti balance scale; HRSD Hamilton rating scale for depression; GSTP Gait spatiotemporal parameters; VO2 oxygen peak uptake; MS-IM Muscle strength isokinetik measures; 6MWT 6-minute walking test; MAS Modified Ashworth scale; MS-MD Muscle strength mechanical device; COPE Coping orientation to problem experienced; MS Type Multiple sclerosis type; RR Remittent recurrent; SP Secondary progressive; PP Primary progressive; ROM Range of movement; VAS visual Analogical Scale; FAC Functional ambulatory scale; FIS Fatigue impact scale; FSS Fatigue severity scale; BBS Berg balance scale; 10m 10-meter walking test; QoL SF-36 Quality of life Short form 36; PHQ-9 Patient health questionnaire; DGI Dynamic gait index; HADS Anxiety and depression scale; MusiQoL Multiple Sclerosis International Quality of Life scale; FRT functional reach test; Rand-36 Random 36 health survey; 3MWT 3-minute walking tests; Ac Accelerometer; WE Wurzburger inventory; MSSS-88 Multiple sclerosis spasticity scale– 88; WHOQoL-bref WHO quality of life bref; AI Ambulatory index; MSIS-29Bref Multiple sclerosis impact scale_29; MRC Medical research council; BDI Beck depression inventory; WHODAS2.0 World health organization disability assessment schedule; GNDS Guy’s neurological disability scale; SOT Sensory organization test; SA Stabilometric assessment; CPET Maximal cardiopulmonary exercise test; FMSC Fatigue scale for motor and cognitive function; SSST Six spot step test; WLT Working load support; MMSE Mini mental state examination; FAB Frontal assessment battery; TST Timed stair test; PASAT Paced auditory serial attention test; Wei-MuS Wurzburger fatigue inventory; COPM Canadian occupational performance measure; FD Falls diary; STS Sit to stand test; MSFCS Multiple sclerosis functional composite; MS-SS Muscle strength static strength; QoL EG-D Quality of life questionnaire; SRT Sit and reach test; 5MWT 5 minute walking test; FBS Fullerton balance scale.